103
Participants
Start Date
July 1, 2016
Primary Completion Date
January 24, 2017
Study Completion Date
January 24, 2017
Benralizumab
Benralizumab SC administered every 4 weeks for 3 doses (Weeks 0, 4, and 8).
Benralizumab Placebo
Placebo administered every 4 weeks for 3 doses (Weeks 0, 4, and 8).
Seasonal influenza virus vaccine
Patients will receive 1 dose of seasonal influenza virus vaccine Intramuscular (IM) at Week 8.
Research Site, North Charleston
Research Site, Miami
Research Site, Miami
Research Site, Aventura
Research Site, Birmingham
Research Site, Minneapolis
Research Site, Bellevue
Research Site, Edmond
Research Site, Oklahoma City
Research Site, Arlington
Research Site, Waco
Research Site, New Braunfels
Research Site, San Antonio
Research Site, San Antonio
Research Site, El Paso
Research Site, Denver
Research Site, Colorado Springs
Research Site, Clinton
Research Site, Mesa
Research Site, Huntington Beach
Research Site, Newport Beach
Research Site, Medford
Research Site, Aurora
Research Site, Northfield
Lead Sponsor
AstraZeneca
INDUSTRY